References
[1] Lomovskaya, N., Otten, S.L., Doi-Katayama, Y., et al. (1999) Doxorubicin overproduction in Streptomyces peucetius: Cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene. Journal of Bacteriology, 181, 305-318.
[2] Laginha, K.M. (2007) Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clinical Cancer Research, 11, 6944-6949.
[3] Liu, Q.-Y. and Tan, B.K.H. (2003) Relationship between anti-oxidant activities and doxorubicin-induced lipid peroxidtion in P388 tumour cells and heart and liver in mice, Clinical and Experimental Pharmacology and Physiology, 30, 185-188.
http://dx.doi.org/10.1046/j.1440-1681.2003.03803.x
[4] Zima, T., Tesar, V., Richardson, P.J., Mantle, D. and Preedy, V.R. (2001) Effects of doxorubicin (adriamycin) and [(1)-1,2-Bis(3,5-dioxopiperazinyl-1yl)]propane (ICRF-187) on skeletal muscle protease activities. Toxicology and Applied Pharmacology, 171, 135-140.
http://dx.doi.org/10.1006/taap.2000.9084
[5] Kaczmarek, A., Brinkman, B.M., Heyndrickx, L., Vandenabeele, P. and Krysko, D.V.J. (2012) Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways. The Journal of Pathology, 226, 598-608.
[6] Friedman, R., Caflisch, A. (2009) Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring. ChemMedChem, 4, 1317-1326.
http://dx.doi.org/10.1006/taap.2000.9084
[7] Gamo, F.-J. et al. (2010) Thousands of chemical starting points for antimalarial lead identification. Nature, 465, 305-310.
http://dx.doi.org/10.1038/nature09107
[8] Quiles, J., Huertas. J., Battino, M., Mataix, J. and Ramirez, T.M. (2002) Antioxidant nutrients and Adriamycin toxicity. Toxicology, 180, 79-95.
http://dx.doi.org/10.1016/S0300-483X(02)00383-9
[9] Reszka, K.J., Mccormick, M.L. and Britigan, B.E. (2003) Oxidation of anthracycline anticancer agents by the peroxidase mimic microperoxidase 11 and hydrogen peroxide, free radical. Biology & Medicine, 35, 78-93.
http://dx.doi.org/10.1016/S0891-5849(03)00238-7
[10] De Beer, E.L., Antonio, E. and Vooest, E.E. (2001) Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: A Review. European J. of Pharmacology, 415, 1-11.
http://dx.doi.org/10.1016/S0014-2999(01)00765-8
[11] Basser, R.L. and Green, M.D. (1993) Strategies for prevention of anthracycline cardiotoxicity, Cancer Treatment Reviews, 19, 57-77.
http://dx.doi.org/10.1016/0305-7372(93)90027-O
[12] Kocak, G., Erbil, K.M., Özdemir, I. Aydemir, S., Sunar, B., Tuncel, M. and Atalay, S. (2003) The protective effect of melatonin on Adriamycin-induced acute cardiac injury. Canadian Journal of Cardiology, 19, 535-541.
[13] Klimtova, I., Simunek, T., Mazurova, Y., Hrdina, R. Gersl, V. and Adamcova, M. (2002) Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits. Human & Experimental Toxicology, 21, 649-657.
http://dx.doi.org/10.1191/0960327102ht311oa
[14] Mostafa, M.G., Mima, T. and Koreaki, M. (2000) S-allylcysteine ameliorates doxorubicin toxicity in the heart and liver in mice. Planta Medica, 66, 148-151.
http://dx.doi.org/10.1055/s-2000-11124
[15] Candussio, L., Decorti, G., Crivellato, E., Granzotto, M., Rosati, A., Giraldi, T. and Bartoli, F. (2002) Toxicologic and pharmacokinetic study of low doses of verapamil combined with doxorubicin. Life Sciences, 71, 3109-3119.
http://dx.doi.org/10.1016/S0024-3205(02)02175-6
[16] Kang, J.K., Lee, Y.J., No, K.-O., Jung, E.Y., Sung, J.H. Kim, Y.B. and Nam, S.Y. (2002) Ginseng intestinal metabolite-1(GIM-I) reduces doxorubicin toxicity in the mouse testis. Reproductive Toxicology, 16, 291-298.
http://dx.doi.org/10.1016/S0890-6238(02)00021-7
[17] Wahdan, H.A. (1998) Causes of the antimicrobial activity of Honey. Infection, 26, 26-31.
http://dx.doi.org/10.1007/BF02768748
[18] Cooper, R. and Molan, P. (1999) The use of Honey as an antiseptic in managing Pseudomonas infection, Journal of Wound Care (England), 8, 161-164.
[19] Zeina, B., Othman, O. and AL-Assad, S. (1996) Effect of Honey versus thyme on Rubella virus survival in vitro. Journal of Alternative and Complementary Medicine (United States), 2, 345-348.
http://dx.doi.org/10.1089/acm.1996.2.345
[20] Dunford, C., Cooper, R., Molan, P. and White, R. (2001) The use of Honey in wound management. Nursing Standard (Royal College of nursing Great Britain, England), 15, 63-68.
[21] Kingslry, A. (2001) The use of Honey in the treatment of infected wounds: Case studies. British J of Nursing (England), 10(22), 13-16.
[22] Elawadan, K.M.E. and El-Drieny, E.A. (2000) In vitro study of various types of Honey and Bee pollen upon different malignant cell line. Journal of Neuro-Oncology, 2, 52.
[23] Efem, S.E., Udoh, K.T. and Iwara, C.I. (1992) The antimicrobial spectrum of Honey and its clinical significance. Infection (Germany), 20, 227-229.
http://dx.doi.org/10.1007/BF02033065
[24] Vardi, A., Barzilay, Z., Linder, N., Cohen, H.A., Paret, G. and Barzilai, A. (1998) Local application of Honey for treatment of neonatal postoperative wound infection. Acta Paediatrica, 87, 429-432.
http://dx.doi.org/10.1111/j.1651-2227.1998.tb01473.x
[25] Gribel, N.V. and Pashinskii, V.G. (1990) The antitumour properties of Honey. Vopr Onkol, 36, 704-709.
[26] Frank, C.L. (1991) Basic toxicology fundamentals, target organs, and risk assessment. 2nd Edition, Hemisphere Publishing Corporation, New York, 77-99.
[27] Windholz, M. (1976) The Merck index an encyclopedia of chemicals and drugs. 9th Edition, Merck and CO, Inc., Rahway, 1313.
[28] Askar, I., Erbas, M.K. and Gurlek, A. (2002) Effect of heparin fractions on the prevention of skin necrosis resulting from adriamycin extravasation: An experimental study. Annals of Plastic Surgery, 49, 297-301.
http://dx.doi.org/10.1097/00000637-200209000-00010
[29] Van Vleet, J.F. and Ferrans, V.J. (1980) Clinical and pathologic features of chronic Adriamycin toxicosis in rabbits, American J Veterinary Research, 41, 1462-1469.
[30] Tonks, A.J., Cooper, R.A., Jones, K.P., Blair, S., Parton, J. and Tonks, A. (2003) Honey stimulates inflammatory cytokine production from monocytes. Cytokine, 21, 242-247.
http://dx.doi.org/10.1016/S1043-4666(03)00092-9
[31] Al-Waili, N.S. (2003) Effects of daily consumption of honey solution on hematological indices and blood levels of minerals and enzymes in normal individuals. Journal of Medicinal Food, 6, 135-140.
http://dx.doi.org/10.1089/109662003322233549
[32] Zaghloul, A.A., El-Shattawy, H.H., Kassem, A.A., Ibrahim, E.A., Reddy, I.K. and Khan, M.A. (2001) Honey, a prospective antibiotic: Extraction, formulation, and stability. Pharmazie, 56, 643-646.
[33] Mitchell, E.P. and Philip, S. (1992) Gastrointestinal toxicity of chemotherapeutic agent. In: Perry, M.C., Ed., The Chemotherapy Source Book, Williams and Wilkins, Baltimore, 620-634.
[34] Melichar, B., Kohout, P., Bratova, M., Solichova, D., Kralickova, P. and Zadak, Z. (2001) Intestinal permeability in patients with chemotherapy-induced stomatitis. Journal of Cancer Research and Clinical Oncology, 127, 314-318.
http://dx.doi.org/10.1007/s004320000209
[35] Herman, E., Zhang, J., Hasinoff, B.B., Clark Jr., J.R. and Ferrans, V.J. (1997) Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the fe(III)-mitoxantrone complex. Journal of Molecular and Cellular Cardiology, 29, 2415-2430.
http://dx.doi.org/10.1006/jmcc.1997.0477
[36] Pearlman, M., Jendiroba, D., Pagliaro, L., Keyhani, A., Liu, B., Freireich, E.J. and Travis, E. (2003) Dexrazoxane’s protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin induced toxicity. Cancer Chemotherapy and Pharmacology, 52, 477-481.
http://dx.doi.org/10.1007/s00280-003-0655-3
[37] Urwi, N.S. (2012) Studies of the effects of aspartame on mice liver. MSc Thesis, University of Taibah, KSA Madina.
[38] Samelis, G.F., Stathopoulos, G.P., Kotsarelis, D., Dontas, I., Frangia, C. and Karayannacos, P.E. (1998) Doxorubicin cardiotixicity and serum lipid increase is prevented by Dextrazoxane (ICRF-187). Anticancer Research, 18, 3305-3310.
[39] Ringenberg, Q.S. (1992) Vascular toxicity. In: Perry, M.C., Ed., The Chemotherapy Source Book, Williams and Wilkins, Baltimore, 680-688.
[40] Kandil, A. and Monir, A. (1986) The effect of Honey on pathologic liver. 4th International Conference on Islamic Medicine, Kuwait, Bulletin of Islamic Medicine, 4, 72-77.
https://getinfo.de/app/ISLAMIC-MEDICAL-THEORY-OF-PREVENTION-AND-TREATMENT/id/BLCP%3ACN069421853
[41] Gershbein, L.L. (1976) Liver regeneration in rats administered high levels of carbohydrates. International Journal for Vitamin and Nutrition Research, 46, 472-479.
[42] Gharzouli, K., Smain, A., Gharzouli, A. and Khennouf, S. (2002) Gastroprotective effects of Honey and glucosefructose-sucrosemaltose mixtureagainst ethanol, indomethacin, and acidified aspirin-induced lesions in the rat. Experimental and Toxicologic Pathology, 54, 217-221.
http://dx.doi.org/10.1078/0940-2993-00255
[43] Saad, S.Y. and Najjar, T.A. and AL-Rikabi, A.C. (2001) The preventive role of deferoxamine against acute Doxorubicin induced cardiac, renal and hepatic toxicity in rats. Pharmacological Research, 43, 211-218.
http://dx.doi.org/10.1006/phrs.2000.0769
[44] Nagai, T., Sakai, M., Inouec, R., Inouec, H. and Suzuki, N. (2001) Antioxidative activities of some commercially honeys, royal jelly and propolis. Food Chemistry, 75, 237-240.
http://dx.doi.org/10.1016/S0308-8146(01)00193-5
[45] Psotova, J., Chlopcikova, S., Miketova, P., Hrbac, J. and Simanek, V. (2004) Chemoprtective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempherol, luteolin, and quercetin. Phytotherapy Research, 18, 516-521.